Objective: To evaluate the impact of implementing commercial whole exome sequencing (WES) and targeted gene panel testing in pregnancies with fetal anomalies.
Methods:A retrospective chart review of 124 patients with sequencing performed by commercial laboratories.
Results:The diagnostic yield of WES and panel testing was 21.5% and 26%, respectively, based on likely pathogenic (LP) or pathogenic (P) variants. Forty-two percent of exomes and 32% of panels analysed had one or more variants of uncertain significance (VUS) reported. A multidisciplinary in-depth review of the fetal phenotype, disease phenotype, variant data, and, in some patients, additional prenatal or postnatal investigations increased the diagnostic yield by 5% for exome analysis and 6% for panel analysis.
Conclusions:The diagnostic yield of WES and panel testing combined was 23% based on LP and P variants. Although the reporting of VUS contributed to a 5% increase in diagnostic yield for WES and 6% for panels, the large number of VUS reported by commercial laboratories has significant resource implications. Our results support the need for greater adherence to the recommendations on the prenatal reporting of VUS and the importance of a multidisciplinary approach that brings together clinical and laboratory expertise in prenatal genetics and genomics.
Key pointsWhat is already known about this topic? � Prenatal exome sequencing in fetuses with structural anomalies identified on ultrasound increases the diagnostic yield by about 31%.
What does this study add?� This study demonstrates that the reporting of variants of uncertain significance (VUS) increases the diagnostic rate by 5%-6%.
pregnancy loss will likely continue to advance. With more use of CMA, our understanding of variants is advancing, and undoubtedly, some small copy number variants can lead to pregnancy loss, but this will only be well understood with use over time.--MEN
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.